ClearBridge Investments - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$9,000
-25.0%
1960.0%0.00%
Q1 2020$12,000
-50.0%
196
-3.0%
0.00%
Q4 2019$24,000
+84.6%
2020.0%0.00%
Q3 2019$13,000
-18.8%
2020.0%0.00%
Q2 2019$16,000
-30.4%
2020.0%0.00%
Q1 2019$23,000
-36.1%
202
-42.9%
0.00%
Q4 2018$36,000
-20.0%
3540.0%0.00%
Q3 2018$45,000
+50.0%
3540.0%0.00%
Q2 2018$30,000
-42.3%
354
-58.0%
0.00%
Q1 2018$52,000
+6.1%
8430.0%0.00%
Q4 2017$49,0000.0%8430.0%0.00%
Q3 2017$49,000
-27.9%
843
+50.3%
0.00%
Q2 2017$68,000
+11.5%
561
+4.3%
0.00%
Q1 2017$61,000
+5.2%
5380.0%0.00%
Q4 2016$58,000
-32.6%
538
+2.9%
0.00%
Q3 2016$86,000
+14.7%
5230.0%0.00%
Q2 2016$75,000
+134.4%
523
+108.4%
0.00%
Q1 2016$32,000
-13.5%
2510.0%0.00%
Q4 2015$37,000
-11.9%
2510.0%0.00%
Q3 2015$42,000
+44.8%
251
+109.2%
0.00%
Q2 2015$29,000
-43.1%
120
-33.3%
0.00%
Q1 2015$51,000
+82.1%
1800.0%0.00%
Q4 2014$28,0001800.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders